Dhein S, Gerwin R, Ziskoven U, Schott M, Rump A F, Zhao Y, Salameh A, Klaus W
Institut für Pharmakologie, Universität Köln, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):643-9. doi: 10.1007/BF00167242.
Isolated perfused spontaneously beating rabbit hearts were treated with increasing concentrations of norepinephrine (0.01, 0.1, 0.5 mumol/l) either alone or in presence of propranolol (0.1 mumol/l). For analysis of the epicardial activation and repolarization process and epicardial mapping (256 unipolar leads) was performed. For each electrode the activation and repolarization time was determined. From these data the "breakthrough-points" (BTP) of epicardial activation were determined. At each electrode an activation vector (VEC) was calculated giving direction and velocity of the local excitation wave. The beat similarity of various heart beats (under NE) compared to control was evaluated by determination of the percentage of identical BTP and of similar VEC (deviation < or = 5 degrees). Moreover at each electrode the local activation recovery interval (ARI) and its standard deviation (of 256 leads, dispersion, DISP) were determined. Norepinephrine alone (0.01, 0.1, 0.5 mumol/l) led to an increase in left ventricular pressure, heart rate and DISP with concomitant frequency dependent reduction in ARI, and to changes in the epicardial activation pattern (reduction in BTP, VEC). We found that in the presence of propranolol (0.1 mumol/l) norepinephrine prolonged ARI and reduced ARI-dispersion. This effect was not due to changes in heart rate. The disturbing effects on the activation pattern were diminished. These effects could be prevented by pretreatment with 1 mumol/l prazosin. From these results we conclude, that norepinephrine prolongs the relative action potential duration via stimulation of alpha 1-adrenoceptor and enhances cellular coupling.(ABSTRACT TRUNCATED AT 250 WORDS)
对离体灌注的兔自发搏动心脏,分别用递增浓度的去甲肾上腺素(0.01、0.1、0.5μmol/L)单独处理或在普萘洛尔(0.1μmol/L)存在的情况下处理。为分析心外膜激活和复极化过程,进行了心外膜标测(256个单极导联)。对每个电极测定激活和复极化时间。根据这些数据确定心外膜激活的“突破点”(BTP)。在每个电极计算激活向量(VEC),给出局部兴奋波的方向和速度。通过确定相同BTP和相似VEC(偏差≤5度)的百分比,评估与对照相比各种心跳(在去甲肾上腺素作用下)的搏动相似性。此外,在每个电极测定局部激活恢复间期(ARI)及其标准差(256个导联的离散度,DISP)。单独使用去甲肾上腺素(0.01、0.1、0.5μmol/L)导致左心室压力、心率和DISP增加,同时ARI随频率依赖性降低,并导致心外膜激活模式改变(BTP、VEC降低)。我们发现,在普萘洛尔(0.1μmol/L)存在的情况下,去甲肾上腺素延长了ARI并降低了ARI离散度。这种作用不是由于心率变化。对激活模式的干扰作用减弱。用1μmol/L哌唑嗪预处理可预防这些作用。根据这些结果我们得出结论,去甲肾上腺素通过刺激α1肾上腺素能受体延长相对动作电位持续时间并增强细胞耦联。(摘要截短于250字)